Real time optimized treatment planning at the time of the implant is desirable for ultrasound-guided transperineal 125I permanent prostate implants. Currently available optimization algorithms are too slow to be used in the operating room. The goal of this work is to develop a robust optimization algorithm, which is suitable for such application. Three different genetic algorithms (sGA, sureGA and securGA) were developed and compared in terms of the number of function evaluations and the corresponding fitness. The optimized dose distribution was achieved by searching the best seed distribution through the minimization of a cost function. The cost function included constraints on the periphery dose of the planned target volume, the dose uniformity within the target volume, and the dose to the critical structure. Adjustment between the peripheral dose, the dose uniformity and critical structure dose can be achieved by varying the weighting factors in the cost function. All plans were evaluated in terms of the dose nonuniformity ratio, the conformation number and the dose volume histograms. Among these three GA algorithms, the securGA provided the best performance. Within 2500 function evaluations, the near optimum results were obtained. For a large target volume (5 cm x 4 cm x 4.5 cm) including urethra with 20 needles, the computer time needed for the optimization was less than 5 min on a HP735 workstation. The results showed that once the best set of parameters was found, they were applicable for all sizes of prostate volume. For a fixed needle geometry, the optimized plan showed much better dose distribution than that of nonoptimized plan. If the critical structure was considered in the optimization, the dose to the critical structure could be minimized. In the cases of irregular and skewed needle geometry, the optimized treatment plans were almost as good as ideal needle geometry. It is concluded that this new genetic algorithm (securGA) allows for an efficient and rapid optimization of dose distribution, which is suitable for real time treatment planning optimization for ultrasound-guided prostate implant.
Varian Medical Systems (Palo Alto, CA) has implemented the Monte Carlo electron dose calculation algorithm (eMC) in the Eclipse treatment planning system. Previous algorithms for electron treatment planning were limited in their calculation ability for small field depth doses and monitor units. An old rule of thumb to approximate the limiting cutout size for an electron field was determined by the lateral scatter equilibrium and approximated by E (MeV)/2.5 in centimeters of water. In this study, we compared eMC calculations and measurements of depth doses, isodose distributions, and monitor units for several different energy and small field cutout size combinations at different SSDs. Measurements were made using EBT film (International Specialty Products, Wayne, NJ) and a PinPoint ion chamber (PTW‐New York Corp., Hicksville, NY). Our results indicate that the eMC algorithm can accurately predict depth doses, isodose distributions, and monitor units (within 2.5%) for field sizes as small as 3.0 cm diameter for energies in the 6 to 20 MeV range at 100 cm SSD. Therefore, the previous energy dependent rule of thumb does not apply to the Eclipse electron Monte Carlo code. However, at extended SSDs (105–110 cm), the results show good agreement (within 4%) only for higher energies (12, 16, and 20 MeV) for a field size of 3 cm.PACS number: 87.53.Hv
The dose distribution from a 32P source has been measured and calculated in order to evaluate its application in endovascular irradiation. The source dimension was 27 mm in length and 0.3 mm in diameter and was embedded in the end of a Ni-Ti wire. Dose measurements were performed using radiochromic film in several specially designed tissue equivalent phantoms. Loevinger's point dose kernel was used for the calculation. The approximate dose rate at a radial distance of 1.5 mm from the center of the source was found to be 6.75 cGy/s per GBq (0.25 cGy/s per mCi), which allows the delivery of a therapeutic dose in a short time interval with a satisfactory homogeneity without stepping the source. However, the dose rate falls off almost exponentially along the radial distance. Therefore it may not be suitable for treating large diameter vessel from a centrally located source. The effect of a curved 32P wire source on the radial dose distribution was also investigated. The results showed that for a maximum bend of 180 degrees the dose rate was increased by as much as 20% along the inner radial distance but decreased by as much as 20% along the outer radial distance compared to the dose along a straight wire. However, for curvatures normally encountered in a clinical situation, the dose rate was changed less than 5%.
Purpose: To compare photon beam data for the 20 Varian linear accelerators (TrueBeam, iX, and EX models) in use at five centers in the same network with the intent to model with one set of beam data in Eclipsec. Methods: Varian linear accelerators, TrueBeam (3), 21 EX, iX, and Trilogy (14), and 6 EX (3), installed between 1999 and 2014 have their 6 MV and 15 MV x‐ray beams reevaluated. Full commissioning, including output factors (St), percent depth doses (PDD), and off‐axis profiles, was recently performed for a TrueBeam with a cc04 ion chamber in an IBA Blue phantom. Similarly, a subset of beam data for each of the other accelerators was measured recently as follows: for 3×3, 10×10, and 30×30 cm2 field sizes, flatness and penumbra (80–20%) were measured at dmax and 10 cm depths, PDD were measured at 10 and 20 cm depths, and St were measured at 5 cm depth. Measurement results for all machines were compared. Results: For 15 high‐energy (6 and 15 MV) and 3 low‐energy machines (6MV only): 1) PDD agreed within 1.4% at 10 and 20 cm depths; 2) penumbra agreed within 1.0 mm at dmax and 10 cm depths; 3) flatness was within 1.3% at dmax and 10 cm depths; and 4) with exception of the three low energy machines, output factors were within 1.1% and 0.5% for 3×3 and 30×30 cm2, respectively. Measurement uncertainty, not quantified here, accounts for some of these differences. Conclusion: Measured beam data from 15 high‐energy Varian linacs are consistent enough that they can be classified using one beam data set in Eclipse. Two additional high‐energy machines are removed from this group until their data are further confirmed. Three low‐energy machines will be in a separate class based upon differences in output factors (St).
We propose a novel plasmon nano-optical antenna that consists of three vertically superimposed discs with different materials. Two symmetrical nanometer-scale Yagi antenna elements with gold-material are embedded into the surface of the middle disc with silicon dioxide. Based on plasmon theory and Yagi antenna principle, we explore the properties of the far-field radiation and near-field transmission of the antenna in near infrared band. It is found that the pattern of the xoy plane in the antenna can be adjusted in arbitrary direction. The far-field pattern and near-field transmission spectrum can be reconfigured by changing the angle a of the Yagi antenna elements in the middle disc. Moreover, we also discuss the influences of the widths and lengths of the elements on the near-field transmission spectrum when a is fixed at 0 degree.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.